Franklin Resources Inc Edwards Lifesciences Corp Transaction History

Franklin Resources Inc

$313 Billion
Q2 2024

A detailed history of Franklin Resources Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Franklin Resources Inc holds 1,168,866 shares of EW stock, worth $78.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,168,866

Previous 1,185,421 1.4%

Holding current value

$78.6 Million

Previous $113 Million 4.69%

% of portfolio

0.03%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $1.4 Million - $1.56 Million	-16,555 Reduced 1.4%	1,168,866 $108 Million
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $4.26 Million - $5.61 Million	58,749 Added 5.21%	1,185,421 $113 Million
Q4 2023 Feb 09, 2024	SELL	$61.71 - $77.76 $10.5 Million - $13.2 Million	-170,150 Reduced 13.12%	1,126,672 $85.9 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $31.8 Million - $42.8 Million	-458,565 Reduced 26.12%	1,296,822 $89.8 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $2.57 Million - $2.97 Million	-31,521 Reduced 1.76%	1,755,387 $166 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $59.9 Million - $68.2 Million	-807,106 Reduced 31.11%	1,786,908 $148 Million
Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $75.4 Million - $96.5 Million	-1,104,141 Reduced 29.86%	2,594,014 $194 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $14.6 Million - $19 Million	-177,113 Reduced 4.57%	3,698,155 $306 Million
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $32.4 Million - $48 Million	-374,035 Reduced 8.8%	3,875,268 $368 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $8.21 Million - $10.3 Million	80,476 Added 1.93%	4,249,303 $500 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $11.4 Million - $14 Million	107,260 Added 2.64%	4,168,827 $540 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $5.49 Million - $6.55 Million	53,357 Added 1.33%	4,061,567 $460 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $241,375 - $301,604	2,879 Added 0.07%	4,008,210 $415 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $16.3 Million - $18.7 Million	-206,543 Reduced 4.9%	4,005,331 $335 Million
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $14.1 Million - $18 Million	-196,927 Reduced 4.47%	4,211,874 $384 Million
Q3 2020 Nov 12, 2020	SELL	$67.19 - $87.44 $3.45 Million - $4.49 Million	-51,370 Reduced 1.15%	4,408,801 $352 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $169 Million - $226 Million	2,941,683 Added 193.72%	4,460,171 $347 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $554,759 - $857,385	-10,585 Reduced 0.69%	1,518,488 $286 Million
Q4 2019 Feb 12, 2020	SELL	$71.7 - $82.09 $764,035 - $874,751	-10,656 Reduced 0.69%	1,529,073 $357 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $2.97 Million - $3.64 Million	48,204 Added 3.23%	1,539,729 $339 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $3.1 Million - $3.59 Million	-55,696 Reduced 3.6%	1,491,525 $276 Million
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $19.3 Million - $25.8 Million	-402,515 Reduced 20.64%	1,547,221 $296 Million
Q4 2018 Feb 12, 2019	SELL	$46.41 - $56.94 $1.68 Million - $2.06 Million	-36,100 Reduced 1.82%	1,949,736 $299 Million
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $2.6 Million - $3.3 Million	-56,925 Reduced 2.79%	1,985,836 $346 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $20,036 - $24,213	472 Added 0.02%	2,042,761 $297 Million
Q1 2018 May 10, 2018	SELL	$37.19 - $47.45 $6,099 - $7,781	-164 Reduced 0.01%	2,042,289 $285 Million
Q4 2017 Feb 14, 2018	SELL	$33.79 - $39.39 $2.83 Million - $3.3 Million	-83,773 Reduced 3.94%	2,042,453 $230 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $77.2 Million - $82.6 Million	2,126,226	2,126,226 $232 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Edwards Lifesciences Corp Transaction History